Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Istari Oncology

Request full access

Istari Oncology, Inc. is a clinical-stage biotechnology company dedicated to developing innovative immuno-oncology and immunotherapy platforms aimed at treating glioblastoma and a broad range of…

Durham, United StatesFounded 2016Biotech & Life Sciences

About Istari Oncology

iStar Oncology is a biotech startup that operates in the field of cancer therapy. The company's primary product is lerapolturev, a treatment based on the live attenuated Sabin type 1 oral polio vaccine. This treatment leverages the immune system's memory response to polio to amplify the anticancer immune response. The company's approach is designed to overcome the challenges faced by immune checkpoint inhibitors, which have revolutionized cancer therapy but are limited by a lack of preexisting anticancer T cells or the inability of these cells to overcome the immunosuppressive tumor environment.

The company's business model revolves around the development and clinical testing of lerapolturev. The drug has been administered to over 200 patients and is currently the subject of multiple ongoing phase 2 trials across various solid tumors. The company's target market includes patients with various types of solid tumors, as the poliovirus receptor, which lerapolturev targets, is present on virtually all solid tumor types.

iStar Oncology generates revenue through the development, testing, and potential future sales of its cancer therapy. The company has received Orphan Drug Designation and Breakthrough Therapy Designation for recurrent glioblastoma (rGBM) from the FDA. It has also been granted Fast Track status for patients with advanced melanoma who have disease progression after anti–PD-1/L1 therapy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
4
Open positions
None listed
Dealroom signal
60.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Apr 2021 $43M $174M Undisclosed —
EARLY VC✓Equity / VC May 2017 $1.1M $4.4M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Istari Oncology website traffic

Latest recorded traffic for Istari Oncology is 190 monthly website visits, down 90% over the last three months. Istari Oncology's team declined 50% over the past year.

Latest monthly visits190 3-month web change-90% 1-year team growth-50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Istari Oncology in the Durham ecosystem

Live from Dealroom

The Istari Oncology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors2 additional known investors

  • Duke University
  • Pappas Capital
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Istari Oncology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Istari Oncology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.